MedTrace Logo

Impact of Perioperative Anesthetic Management on Renal Cancer Progression.

NCT06536244 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-08-02

No results posted yet for this study

Summary

The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.

Conditions

  • Perioperative Anesthetic
  • Renal Cancer

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Juan P Cata, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2026-09-01
Completion
2028-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06536244 on ClinicalTrials.gov